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The granulosa layer and theca interna in ovarian follicles contain ANG II receptors that are predominantly AT 2 (12, 18, 27, 29) . In addition, human follicular fluid contains angiotensinogen, prorenin, ANG I, and ANG II, the concentration of which is more than 11 times greater than that found in plasma (3, 7) . The concentration of rat ovarian ANG II is also 8-to 75-fold higher than that found in plasma and is not reduced in bilaterally nephrectomized rats (12) . These data indicate that ANG II is locally produced in the ovary, but the physiological roles of ANG II via AT 2 in the ovary have not yet been defined. Several reports suggest that ANG II is involved in the regulation of follicle atresia where granulosa cells undergo apoptosis. Daud et al. (5) first showed that AT 2 is exclusively expressed in atretic follicles of adult rats during all stages of the estrous cycle, whereas AT 1 is associated with other ovarian structures including blood vessels. Pucell et al. (26) demonstrated that AT 2 expression is inhibited in rat cultured granulosa cells by follicle-stimulating hormone (FSH), a crucial factor for survival and differentiation of granulosa cells, whereas the expression of most receptors for hormones and growth factors related to follicle maturation, such as epidermal growth factor, luteinizing hormone (LH), and prolactin, is induced by FSH (9) . We recently demonstrated that the AT 2 content in cultured granulosa cells increases under conditions in which apoptosis of the cells is observed (30) . Kitzman and Hutz (15) indicated that ANG II treatment of hamster follicles cultured in vitro reduces the estradiol-to-androgen ratio and induces morphological changes in the theca interna that are observed in atresia. Mukhopadhyay et al. (20) showed that levels of the renin precursor prorenin in follicular fluid are associated with follicle atresia in the bovine ovary. Regardless of these findings, no concrete evidence has shown that ANG II regulates the onset and/or progression of follicle atresia via AT 2 . This is because the localization of AT 2 and the change in its expression level with the onset and progression of follicle atresia are not clear, and the effect of ANG II via AT 2 on the roles of FSH also remains obscure.
Recent reports indicated that FSH activates extracellular signal-regulated kinases (ERK1 and ERK2) in rat and porcine cultured granulosa cells (2, 4) . ERKs belong to the mitogen-activated protein kinases (MAPKs), which are activated in response to a variety of stimuli involved in cell proliferation, survival, and differentiation (17) . For example, withdrawal of nerve growth factor (NGF), a survival and differentiation factor for neural cells, from rat PC12 pheochromocytoma cells led to inhibition of ERKs, resulting in apoptosis of these cells (31) . Also, experiments with PC12 cells suggested that the difference in the duration of ERK activation may be critical for decisions about proliferation vs. differentiation (17) . Therefore, the effect of ANG II via AT 2 on FSH-induced ERK activation must be very important for determining the fate of granulosa cells.
Moderate doses of equine chorionic gonadotropin (eCG) stimulate the growth and development of ovarian follicles for 2-3 days, after which the follicles undergo atresia because of waning levels of trophic support caused by metabolism of the gonadotropin (24) . This eCG-induced model shows follicle atresia morphologically identical to that occurring in untreated adult animals (23) . In the present study, we examined AT 2 expression at both the mRNA and protein levels during the onset and progression of atresia in vivo with this rat model. Furthermore, we studied the effect of ANG II on the abilities of FSH to prevent apoptosis and to differentiate ovarian granulosa cells and to activate ERKs in vitro prepared from immature female rats treated with diethylstilbestrol (DES) or eCG.
MATERIALS AND METHODS
Reagents. Ovine FSH was kindly provided by the National Institutes of Health (Bethesda, MD). This compound (NIH-FSH) is also known as NIDDK-oFSH-15 or AFP-5529C. The potency of NIH-FSH is 20 times greater than that of NIH-FSH-S1. By weight, the LH potency of NIH-FSH is 0.04 times that of NIH-LH-SI, and that of prolactin is less than 0.001 times that of NIH-PRL. eCG, DES, Hanks' balanced salt solution (HBSS), and myelin basic protein were purchased from Sigma (St. Louis, MO). Modified McCoy's 5A medium (pH 7.4) was prepared with McCoy's 5A (GIBCO Life Technologies) supplemented with 25 mM HEPES, 26 mM NaHCO 3 , 2 mM L-glutamine (Sigma), 100 µg/ml streptomycin, and 100 IU/ml penicillin (GIBCO Life Technologies). ANG II, leupeptin, and antipain were purchased from the Peptide Institute (Osaka, Japan Hormone administration. Immature female Wistar-Imamichi rats obtained from the Imamichi Institute for Animal Reproduction (Ibaraki, Japan) were housed in air-conditioned quarters with a 12:12-h light-dark cycle. For in vivo experiments, 23-day-old rats were subcutaneously injected with 20 IU of eCG for 3-6 days. The rats were killed by decapitation under mild ether anesthesia on each of days 3-6 after injection, and the ovaries were removed. For autoradiographic studies, ovaries were snap-frozen in a dry iceisopentane bath and stored at Ϫ80°C. For in situ 3Ј-end labeling analysis, ovaries were immersion-fixed in 10% buffered formalin for 7 days at room temperature. Granulosa cells were prepared as described by Knecht et al. (16) to extract total RNA and for binding studies. For in vitro experiments, one set of rats was implanted subcutaneously with Silastic 10-mm capsules containing DES at 21 days of age to stimulate granulosa cell proliferation. The other set of animals (23 days old) was subcutaneously injected with 20 IU of eCG to induce preovulatory follicles. Five days after DES implantation and 48 h after eCG injection, the animals were anesthetized with ether and decapitated, and then the ovaries were removed.
Preparation of granulosa cells. Granulosa cells were prepared according to the method of Knecht et al. (16) . Briefly, after the intercellular gap junctions were disrupted with 6.8 mM EGTA and 0.5 M sucrose, granulosa cells were released by puncturing the ovaries with a 27-gauge needle and pressing the remaining cells through a 40-mesh stainless steel grid. Thereafter, cells were washed and pelleted by gentle centrifugation (200 g, 5 min, room temperature) and then snap-frozen in liquid nitrogen at Ϫ80°C until DNA and total RNA extraction. The remaining cells were resuspended in McCoy's 5A medium in 12 ϫ 75-mm polystyrene tubes and were cultured in an incubator at 37°C with a humidified gas mixture of 5% CO 2 -95% room air for 48 h with or without various additives.
In subsequent experiments of MAPK activity, the granulosa cell cultures were plated for 48 h in 10% fetal calf serum and cultured for an additional day in serum-free media.
In situ 3Ј-end labeling. Ovaries were paraffin-embedded, sectioned at 8-µm thickness from the center, and mounted on microscope slides. The sections were deparaffinized by heating for 30 min at 60°C followed by two 5-min washes in xylene and were rehydrated through a graded ethanol series and double-distilled water. Protein was removed from tissues by an incubation with 20 µg/ml proteinase K (Sigma) for 15 min at room temperature; then endogenous peroxidase was inactivated by immersion in 3% H 2 O 2 in ethanol for 5 min. DNA was labeled at 3Ј-ends with biotinylated 2Ј-deoxyuridine 5Ј-triphosphate biotin-16-dUTP; Boehringer Mannheim, Mannheim, Germany) by an incubation with reaction buffer consisting of 300 mM Tris · HCl (pH 7.4), 140 mM (CH 3 ) 2 AsO 2 Na, and 1 mM CoCl 2 containing terminal deoxynucleotidyl transferase for 30 min at 37°C. The sections were incubated for 1 h at 37°C in Vectastain avidin-biotin complexperoxidase standard solution (Vector Laboratories, Burlingame, CA). Diaminobenzidine (Dojin, Kumamoto, Japan), a substrate for peroxidase, was applied to the slides for the color reaction, and then sections were stained with hematoxylin and eosin. Negative controls were sections incubated with reaction mixtures in the absence of terminal deoxynucleotidyl transferase.
ANG II receptor autoradiography. Ovarian sections (20 µm) were cut in a cryostat, attached to gelatinized slides (Wako Pure Chemical, Osaka, Japan), air-dried at 4°C, and stored at Ϫ80°C. Sections were incubated for 15 min at room temperature in incubation buffer containing 0.2% BSA and 0.5 mg/ml bacitracin (Nakarai Tesque, Kyoto, Japan) and were placed for 1 h at room temperature in incubation buffer containing 0.5 nM 125 I-[Sar 1 ,Ile 8 ]ANG II, 0.2% BSA, and 0.5 mg/ml bacitracin with or without several agonists and antagonists. The sections were then sequentially rinsed in ice-cold wash buffer (10 mM Na 2 HPO 4 /150 mM NaCl/5 mM EDTA/0.02% NaN 3 ) four times and dried under a stream of cold air for 1 h. Slides were exposed to X-ray film (Eastman Kodak, Rochester, NY) for 5 to 6 days and then stained with hematoxylin and eosin.
DNA isolation and analysis. Low-molecular-weight DNA was extracted from granulosa cells isolated from the ovaries of rats killed on each of days 3-6 after eCG injection or from cultured granulosa cells. Cells were gently homogenized in a 300 mM Tris · HCl (pH 7.4) containing 100 mM NaCl, 10 mM EDTA, and 200 mM sucrose, and then incubated in 0.5% SDS at 65°C for 30 min to facilitate membrane and protein disruption. The samples were cooled on ice for 60 min in 1 M potassium acetate to precipitate protein and were clarified by centrifugation at 5,000 g for 10 min at 4°C. The supernatant was then extracted with phenol-chloroform, precipitated in ethanol, and resuspended in TE buffer (10 mM Tris · HCl-1 mM EDTA, pH 8.0). After RNase digestion (100 µg/ml) at 37°C for 60 min, samples were again extracted with phenolchloroform, precipitated in ethanol, and resuspended in water. Thereafter, DNA samples (4 µg) were resolved through 2% agarose gels, stained with ethidium bromide, and visualized under ultraviolet light.
Quantitative RT-PCR analysis of AT 2 mRNA. Total RNA (1.2 µg) isolated from granulosa cells was reverse transcribed with random primers. The resultant cDNA mixtures were amplified by PCR to selectively detect AT 2 mRNA in the presence of a known amount of deletion-mutated AT 2 cDNA with a trace amount of [␣-32 P]dCTP with the following primers (6): 5Ј-TATGCTCAGTGGTCTGCT-3Ј (sense primer, nucleotides 610-627 of a cDNA for rat AT 2 ) and 5Ј-CCACTAA-CAGATTTAAGACAC-3Ј (antisense primer, nucleotides 1,084-1,104) (14, 21) . Denaturation, annealing, and the polymerase reaction proceeded at 94°C for 1 min, at 55°C for 1 min, and at 72°C for 1.5 min, respectively. After 20 cycles of amplification, the incubation was continued at 72°C for another 8.5 min to complete polymerization. Native AT 2 cDNA produces a 495-bp fragment, whereas deletion-mutated AT 2 cDNA generates a fragment of 425 bp. The PCR products were size-fractionated on 5% acrylamide gels. The gels were dried and examined with a BAS-2000 imaging analyzer (Fuji Film, Tokyo, Japan). The radioactivity of the PCR product obtained from the target cDNA was divided by that from the deletion-mutated cDNA.
The resultant values were normalized to the amount of ␤-actin mRNA, which was also determined in the same method as AT 2 Binding of 125 I-hCG. After culture, cells (1 ϫ 10 6 cells/tube) were immersed in acid buffer, washed twice with HBSS, and then reacted with 125 I-hCG at a final concentration of 10 ng/ml in 200 µl of binding buffer at 22°C for 17 h. Nonspecific binding was determined by incubating the cells with 25 µg/ml unlabeled hCG. Free and bound radioligands were separated by centrifugation; then radioactivity was assayed by ␥-scintillation counting.
Measurement of estradiol-17␤. Estradiol-17␤ was measured with an enzyme immunoassay (EIA) kit (Cayman Chemical, MI). The cross-reactivity of the antiserum used in the estradiol-17␤ assay was 100% for estradiol-17␤, 7.5% for estrone, 0.3% for estriol, 0.1% for testosterone and dihydrotestosterone-5␣, and Ͻ0.01% for C 21 and other C 19 and C 18 steroids. The minimum detectable amount of the steroid assay was 9.2 pg/ml. Intra-and interassay coefficients of variation were Ͻ10%.
MAPK activity. Control and various additive-treated granulosa cell cultures were rinsed with three changes of ice-cold phosphate-buffered saline (pH 7.4) and immediately scraped on ice in lysis buffer [20 mM HEPES, pH 7.2, 25 mM NaCl, 2 mM EGTA, 1 mM EDTA, 0.2 mM DTT, 0.1% Triton X-100, 50 mM NaF, 1 mM Na 3 VO 4 , 25 mM ␤-glycerophosphate, and protease inhibitor mixture tablet (Boehringer Mannheim)]. Cell lysates were centrifuged at 12,000 g for 10 min at 4°C. Supernatants were removed, and protein concentrations were assayed with the bicinchoninic acid protein assay reagent (Pierce, Rockford, IL). MAPK activity within the supernatant was analyzed with the in-gel kinase method. Cell extracts (25 µg total protein/lane) were separated by 10% SDS-polyacrylamide gel electrophoresis with 0.5 mg/ml of myelin basic protein copolymerized in the running gel. After electrophoresis, the gel was washed twice for 30 min with 50 mM Tris (pH 8.0) and 20% isopropyl alcohol followed by two changes of a buffer containing 50 mM Tris (pH 8
P]ATP onto the renatured gel followed by incubation at 25°C for 1 h. Thereafter, the gel was washed with 5% trichloroacetic acid and 1% sodium pyrophosphate to remove unreacted [␥-32 P]ATP. Thereafter, the gel was dried and examined with a BAS-2000 imaging analyzer.
Data analysis. Data are presented as means Ϯ SE of several independent experiments. The effects of various treatments on different culture groups were compared by one-way ANOVA, followed by the post hoc Student-NewmanKeuls test. A difference of P Ͻ 0.05 was considered significant.
RESULTS
Effects of eCG on ovarian morphology and DNA fragmentation. The apoptic death of granulosa cells is the molecular mechanism underlying follicle atresia (10) . We initially examined the time course of the effect of eCG injection on ovarian DNA degradation, a characteristic of apoptosis, by treating immature female rats with 20 IU eCG at 23 days of age. The electrophoretic profile of low-molecular-weight DNA fragments obtained from granulosa cell lysates on each of days 3-6 after eCG injection is shown in Fig. 1 . Granulosa cells obtained 3 days postinjection lacked signals indicating low-molecular-weight DNA. However, light fragments were discernible on day 4. On days 5 and 6, oligonucleosomal length DNA fragments formed an obvious ladder.
To study the specific ovarian cell types exhibiting apoptotic DNA degradation after eCG injection, DNA on histological sections of ovaries was 3Ј-end labeled with biotin-16-dUTP as shown in Fig. 2 . Incorporation of biotin-16-dUTP after the terminal transferase reaction was detected with avidin conjugated to peroxidase. In ovaries obtained 4 but not 3 days after eCG injection, low levels of DNA were 3Ј-end labeled in granulosa cells in a small population of atretic follicles. In contrast, in ovaries obtained on days 5 and 6, biotin-16-dUTP was incorporated into the granulosa cell layer of many atretic follicles. Although oocytes were also labeled in some follicles, theca cells were not labeled in the same follicles where granulosa cells were heavily labeled. In follicles with antral cavities, antral granulosa cells were frequently labeled more heavily than mural granulosa cells. In some of these follicles, the antral cavity was also positive, probably because of the presence of cell-free DNA fragments.
Effects of eCG on AT 2 content at the protein and mRNA levels. To investigate the levels of AT 2 during the onset and progression of atresia, granulosa cells were obtained from rats on each of days 3-6 after eCG injection. To specifically detect AT 2 , cells were exposed to DTT, which considerably decreases the ligand binding activity of AT 1 and enhances that of AT 2 without affecting antagonist selectivity (18) . Figure 3 shows that the binding of 125 I-[Sar 1 ,Ile 8 ]ANG II, a subtypenonselective antagonist, was noticeably and time dependently increased 3-6 days after eCG injection.
Because follicles containing AT 2 in the adult rat ovary are mainly atretic throughout the estrous cycle (5), we studied the cellular localization of AT 2 Figure 4 , top, shows that ANG II receptors in granulosa cells were AT 2 , whereas those on other ovarian structures were AT 1 . As indicated in Fig.  4 , bottom, the radioligand binding localizing in the granulosa cell layer was markedly and time dependently increased from days 3 to 6.
To determine the levels of AT 2 mRNA during follicle atresia, total RNA was extracted from ovaries on each Figure 5 shows that the AT 2 mRNA level increased from days 3 to 6 in a timedependent fashion. Therefore, the time course of the increased AT 2 content at both protein and mRNA levels agrees well with that of the progression of follicle atresia, suggesting a close relationship between AT 2 and atresia.
Effects of ANG II on FSH actions in cultured granulosa cells.
To determine the biological roles of ANG II via AT 2 in follicle atresia, we studied the effects of ANG II on the actions of FSH in cultured granulosa cells, because FSH is a crucial differentiation and survival factor for these cells. We focused on the abilities of FSH to prevent apoptosis (10) , to induce the LH receptor expression (9) , and to enhance steroidogenesis (9) .
As shown in Fig. 6 , DNA prepared from rats 2 days after eCG injection was cleaved in serum-free media during a 48-h culture. ANG II did not affect DNA fragmentation. Although FSH decreased apoptotic DNA fragmentation compared with untreated controls, this decrease was prevented by ANG II. Figure 7 shows the effect of ANG II on 125 I-hCG binding to the LH receptor of granulosa cells prepared from DES-treated rats. After a 48-h incubation, FSH caused an 8.5-fold increase in 125 I-hCG binding compared with untreated controls (P Ͻ 0.05). In contrast, ANG II inhibited the FSH-stimulated binding of 125 I- Similarly, Fig. 8 indicates the effect of ANG II on estrogen production in cultured granulosa cells. After a 48-h incubation, FSH induced a 2.4-fold increase in estrogen production compared with untreated controls (P Ͻ 0.05). ANG II suppressed FSH-stimulated estrogen production by 36% (P Ͻ 0.05). This ANG II effect was reversed by PD-123319 (P Ͻ 0.05) but not by DuP-753. ERKs (ERK1 and ERK2) are key enzymes in the regulation of a variety of cellular events, including cell differentiation, survival, and apoptosis. To know the mechanism of the inhibitory effects of ANG II on FSH actions described above, we measured FSH-induced ERK activation in the presence or absence of ANG II by in-gel kinase assay. The activities of both ERK1 and ERK2 were rapidly increased after FSH treatment, with a peak at 2 min, and declined to basal levels within 30 min (data not shown). ANG II inhibited FSH-stimulated ERK activities (data not shown). To selectively investigate the role of AT 2 , we examined the effect of the AT 2 -specific agonist CGP-42112B on FSHstimulated ERK activities. CGP-42112B is known to act as an agonist for AT 2 but as an antagonist for AT 1 at a concentration in this study (1 µM). As shown in Fig. 9 , after a 2-min incubation, FSH induced a 1.8-fold and a 1.6-fold increase in ERK1 and ERK2 activities, respectively (P Ͻ 0.05), whereas CGP-42112B inhibited these FSH-caused increases (P Ͻ 0.05). This CGP-42112B effect was reversed by PD-123319 (P Ͻ 0.05).
DISCUSSION
In addition to gonadotropins, several growth factors, cytokines, and vasoactive peptides are implicated in the regulation of follicle development and atresia. In contrast to the regulatory mechanisms underlying follicle development, little is known about the regulation of atresia, which is the ultimate fate of most follicles. The vasoactive peptide ANG II is one of such ovarian factors. Ovarian ANG II receptors are predominantly AT 2 , but their physiological roles remain to be resolved. Therefore, the ovary is a useful model with which to investigate novel roles of the renin-angiotensin system (RAS) through AT 2 , functions that are unrelated to the regulation of blood pressure and fluid osmolarity. However, although AT 2 is predominantly expressed in atretic follicles, AT 2 has not been conclusively implicated in the regulation of atresia. In this study, we examined immature model rats injected with eCG, in which ovarian follicles undergo growth and development with subsequent atresia, in addition to investigating granulosa cells in primary culture. Our data suggest that AT 2 stimulation causes the progression of follicle atresia through granulosa cell apoptosis by inhibiting FSH actions, mainly because of the following findings. First, the AT 2 content in vivo was increased at both protein and mRNA levels in parallel with the progression of follicle atresia. This increase was not observed before the onset of atresia. If AT 2 is involved in the fate of follicles, considerable levels of AT 2 should be detected in some healthy follicles. Thus the implication of AT 2 in the progression of atresia is more likely than in the onset of atresia. Second, AT 2 stimulation inhibited the in vitro actions of FSH, which plays crucial roles for survival and differentiation of granulosa cells. That is, FSH-induced DNA fragmentation and FSH-caused increases in the LH receptor content and estrogen production were all inhibited. Also, AT 2 stimulation inhibited FSH-induced ERK activation, enzymes that are critical for cell survival and differentiation. Enhancement of estrogen biosynthesis and the increase in the LH receptor content are the parameters for FSH-stimulated differentiation of cultured granulosa cells (9) .
In contrast to our findings, several reports (25, 33, 34) indicate that ANG II may be involved in the induction of follicle development, steroidogenesis, oocytes maturation, and ovulation, rather than with atresia. For example, ANG II stimulated estrogen production, oocytes maturation, and ovulation in in vitro-perfused rabbit ovaries, and these ANG II effects were mediated by AT 2 . No convincing rationale can explain this discrepancy, but a species difference might have some relevance. An autoradiographic study has demonstrated a high degree of localization of AT 2 in the granulosa cell layers and the stroma of rabbit preovulatory follicles (33, 34) , whereas our results and those of another (5) revealed intense signals for AT 2 on atretic follicles in the rat ovary. Also, the rabbit estrous cycle differs from cycles of rats and humans. That is, copulatory stimulation induces ovulation in the rabbit. Pucell and co-workers (25, 27) have also demonstrated that ANG II stimulated estrogen secretion in quartered ovaries from eCG-treated immature rats and that ANG II did not affect aromatase activity in cultured granulosa cells prepared from DES-treated rats. Our data are not in agreement with these findings. This can be explained by experimental conditions. Pucell et al. (27) showed that ANG II (1-100 nM) does not affect FSH (100 ng/ml)-induced estrogen production. We examined the effect of ANG II on FSH-stimulated estrogen production in the presence of 50, 100, and 200 ng/ml FSH with or without 1, 10, or 100 nM ANG II (data not shown). FSH significantly stimulated estrogen production in a concentration-dependent manner. ANG II did not affect the estrogen production induced by 100 or 200 ng/ml FSH, whereas 100 nM ANG II suppressed the increase in estrogen production induced by 50 ng/ml FSH. Nevertheless, our findings that the increase in AT 2 expression exhibits close space and time correlation with follicle atresia in vivo and that AT 2 mediates inhibition of FSH actions in vitro are consistent with the fact that AT 2 is predominantly expressed in atretic follicles of adult rats at all stages of the estrous cycle. It has been proposed that ANG II receptors would become undetectable in healthy follicles because of downregulation or by blockade of the binding of exogenous radiolabeled ANG II in receptor binding studies, because preovulatory follicles contain high levels of endogenous ANG II. However, we found that AT 2 mRNA levels increased in parallel with the progression of atresia, suggesting that this notion is unlikely.
The AT 2 -mediated induction of apoptosis in granulosa cells is consistent with the results of several investigations. For example, Kakuchi et al. (13) found by in situ hybridization that sites of AT 2 expression overlap closely with those of a specific group of cells undergoing apoptosis during nephrogenesis in fetal mice. Yamada et al. (32) reported that ANG II induces the apoptosis of PC12W cells cultured in the presence of low concentrations of NGF via AT 2 . Xia et al. (31) also found that withdrawal of NGF from PC12 cells led to inhibition of ERK activity, resulting in apoptosis of these cells.
Androgen is a potential atretogenic factor (10) . Estrogen is thought to prevent the apoptosis of granulosa cells, in part by suppressing the atretogenic effect of androgen (11) . We demonstrated that ANG II inhibits FSH-induced estrogen production via AT 2 in granulosa cells. This finding further supports the thought that AT 2 is involved in follicle atresia involving granulosa cell apoptosis. On the other hand, FSH induces follicle maturation with an increase in the LH receptor content. Preovulatory follicles expressing increased levels of LH receptors ovulate in response to an LH surge. The present study showed that this FSH-induced increase in the LH receptor content was considerably inhibited by AT 2 . Therefore, AT 2 stimulation should decrease the response of follicles to LH, which would lead to a decrease in the rate of ovulation and progression of atresia.
Some reports suggest that the ovarian RAS is associated in humans with polycystic ovary syndrome (PCOS), which can be identified by various symptoms such as chronic anovulation, inappropriate gonadotropin secretion, and hyperandrogenism, depending on the patient (33) . Basal plasma levels of prorenin in PCOS patients are higher than those in follicular-phase controls and significantly correlate with peripheral androgen concentrations. Serum concentrations of total renin are also particularly enhanced in women with PCOS. Moreover, both theca and granulosa cells in large cystic follicles of PCOS intensely immunostain for renin and ANG II, as do granulosa cells of atretic follicles of normal ovaries. These findings raised the possibility that increased levels of ANG II in the ovary may contribute to the cause of PCOS through AT 2 . The estrogen-to-androgen ratios are similarly low in follicles from PCOS and in atretic follicles from normal ovaries. The number of LH receptors in cell samples from cystic follicles obtained by wedge resection from patients with PCOS is significantly lower than that in normal preovulatory follicles. These findings suggested that dysregulation of the RAS is involved in the development of PCOS, because AT 2 may be able to induce follicle atresia with a low ratio of estrogen to androgen and low levels of LH receptors as described above. The ovarian RAS may be one target to consider when designing a strategy to treat such functional ovarian disorders.
Recent studies indicated that AT 2 activates protein tyrosine phosphatase, serine-threonine phosphatase, and the delayed rectifier K ϩ current and inhibits T-type Ca 2ϩ channels (1, 19) . However, the signaling pathways of AT 2 are still far from being completely understood. Our data revealed that stimulation of AT 2 inhibits FSH-induced ERK activation in granulosa cells. Further studies are necessary to gain insight as to how AT 2 mediates apoptosis and how AT 2 mediates inhibition of ERK activities and to understand the relation between apoptosis and ERK activities in these cells. Ovarian granulosa cells provide a useful tool for studying not only unknown signaling pathways of AT 2 but also novel function of the RAS.
